Zions Bancorporation N.A. Has $963,000 Holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC)

Zions Bancorporation N.A. lifted its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 108.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,180 shares of the medical technology company’s stock after buying an additional 89,992 shares during the quarter. Zions Bancorporation N.A.’s holdings in Alphatec were worth $963,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of ATEC. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Alphatec by 7.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 48,031 shares of the medical technology company’s stock worth $662,000 after buying an additional 3,363 shares during the period. BNP Paribas Financial Markets boosted its stake in Alphatec by 276.1% during the first quarter. BNP Paribas Financial Markets now owns 99,790 shares of the medical technology company’s stock worth $1,376,000 after acquiring an additional 73,257 shares in the last quarter. Swiss National Bank boosted its stake in Alphatec by 1.4% during the first quarter. Swiss National Bank now owns 188,300 shares of the medical technology company’s stock worth $2,597,000 after acquiring an additional 2,600 shares in the last quarter. ProShare Advisors LLC boosted its stake in Alphatec by 8.5% during the first quarter. ProShare Advisors LLC now owns 16,572 shares of the medical technology company’s stock worth $229,000 after acquiring an additional 1,304 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Alphatec by 1.2% during the first quarter. Vanguard Group Inc. now owns 5,458,847 shares of the medical technology company’s stock worth $75,278,000 after acquiring an additional 64,648 shares in the last quarter. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently issued reports on ATEC shares. Stifel Nicolaus cut their target price on shares of Alphatec from $19.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Alphatec in a research note on Friday, August 30th. Needham & Company LLC reaffirmed a “buy” rating and issued a $13.00 price objective on shares of Alphatec in a research note on Thursday, October 31st. Piper Sandler dropped their price target on shares of Alphatec from $17.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, August 1st. Finally, HC Wainwright reissued a “buy” rating and set a $20.00 price target on shares of Alphatec in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $17.00.

Insider Transactions at Alphatec

In other news, Director David M. Demski acquired 50,000 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was bought at an average cost of $5.67 per share, for a total transaction of $283,500.00. Following the completion of the transaction, the director now owns 288,441 shares of the company’s stock, valued at $1,635,460.47. The trade was a 20.97 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 22.80% of the company’s stock.

Alphatec Price Performance

ATEC opened at $8.73 on Friday. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of -6.82 and a beta of 1.31. The company has a quick ratio of 1.15, a current ratio of 2.32 and a debt-to-equity ratio of 30.21. The firm has a 50-day moving average price of $6.26 and a 200-day moving average price of $8.42. Alphatec Holdings, Inc. has a twelve month low of $4.88 and a twelve month high of $17.34.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.